Newsletter | October 5, 2024

10.05.24 -- September's Most Popular Articles & Solutions

FEATURED EDITORIAL

FDA Guidance About Delaying, Denying, Limiting, Or Refusing An Inspection

The FDA has finalized a guidance on the circumstances that constitute delaying, denying, limiting, or refusing a drug or device inspection. They also provide reasons that may cause drugs or devices to be adulterated under the FD&C Act.

Breast Reconstruction In The U.S.: Procedure Preferences & Market Trends

This article shares new market research focusing on three segments of the U.S. breast reconstruction market: allografts, xenografts, and synthetics. 

Does My Medical Device Design Actually Work?

In medical device development, the proof of feasibility stage often includes preliminary testing, but also detailed technical, usability, manufacturability, regulatory, and commercial assessments.

TOP INDUSTRY INSIGHTS

Current Trends In Medical Kit Packaging

Today’s version of the medical procedure kit comprises stackable, efficient, sterile, and identifiable trays or pouches stocked with essential equipment for specific surgeries, tests, and examinations. 

Why Engineers Water Down Part Design

Discover why designing for manufacturability shouldn't mean settling for less, but rather striving for innovation with every micron.

A New Mindset For Combination Product Development

As we balance the time-to-market and risk for novel therapies, we must anticipate changing needs for combination device development, highlighting the technological paradigm shift.

TOP RESOURCES

Navigating PFAS In Medical Devices

Stainless Steel Needles: Quantifying Cobalt Risk For EU Regulation

Lifecycle Planning For Containment And Delivery Of Biologics Drug Products

Connect With Med Device Online: